Headlines
-
PDL warns on S8 dispensing
Thursday | Mar 29 2018PHARMACEUTICAL Defence Limited has noted a recent AHPRA investigation of a pharmacist proprietor, alleging that the pharmacy failed to appropriately control the dispensing of Endone to an employee of an aged care facility.
-
Pharmacy sector turnaround
Wednesday | Mar 28 2018INDUSTRY analyst IBISWorld says the development of more sustainable pharmacy models and an increasingly affluent ageing population are likely to see growth in overall pharmacy revenue over the next five years, reversing a decline apparent since 2008/09.
-
PSA NIP push for pharmacy
Wednesday | Mar 28 2018THE Pharmaceutical Society of Australia has urged the Federal Government to remunerate pharmacists through the National Immunisation Program (NIP), in line with payments for other health care professionals providing the service, such as nurses and GPs.
-
TGA defends codeine stance
Tuesday | Mar 27 2018THE Therapeutic Goods Administration has strongly affirmed its advice to Health Minister Greg Hunt about the number of deaths attributed to OTC codeine, rebutting claims to the contrary in an ABC 'Fact Check' article last week (PD yesterday).
-
Arrow targets DAA market
Tuesday | Mar 27 2018ARROW Pharmaceuticals has set its sights firmly on the Dose Administration Aid (DAA) market in Australia, announcing the formation of a new joint venture with NZ firm Douglas Pharmaceuticals called MyPak Solutions (PD breaking news).
-
Of standards & chaperones
Tuesday | Mar 27 2018THE Pharmacy Board of Australia, in conjunction with other Boards and the Australian Health Practitioner Regulation Agency, has started a new process to consider accreditation arrangements from mid-2019.
-
50% flu shot uptake fear
Tuesday | Mar 27 2018THE Pharmacy Guild has launched a concerted push to raise awareness of influenza vaccination via pharmacy, with the release of new research indicating one in two Australian adults don't plan to vaccinate against flu this year.
-
$1.5m for UTS CM research
Monday | Mar 26 2018UTS Sydney's Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) has been awarded $1.5 million in funding from the Blackmores Foundation, Bioceuticals and the Jacka Foundation.
-
Pfizer OTC division sale fail
Monday | Mar 26 2018PHARMACEUTICAL behemoth Pfizer has lost the last bidder for the sale of its OTC business, which includes Advil, Centrum and Chapstick ranges, with GSK announcing it is pulling from the auction field.
-
Pharmacist found ‘unfit’
Friday | Mar 23 2018THE NSW Health Care Complaints Commission (HCCC) has prosecuted a complaint against pharmacist Nicholas Fearon before the NSW Civil and Administrative Tribunal, which found him guilty of unsatisfactory professional conduct and professional misconduct, and having been convicted of a criminal offence in NSW, was not a suitable person to hold registration as a pharmacist.